Ruxolitinib (INCB018424) CAS:941678-49-5
Ruxolitinib (INCB018424)  
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-2385 | 200mg | 250.00 | + Add to cart  | 
																					|
| R-C-2385 | 500mg | 425.00 | + Add to cart  | 
																					|
| R-C-2385 | 1g | 600.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							Ruxolitinib(INCB018424)is the first potent,selective,JAK1/2 inhibitor to enter the clinic with IC50 of 3.3nM/2.8nM in cell-free assays,>130-fold selectivity for JAK1/2 versus JAK3.Ruxolitinib kills tumor cells through toxic mitophagy. Ruxolitinib induces autophagy and enhances apoptosis.
| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 3 weeks | 
| Stability | 2 years | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---Ruxolitinib (INCB018424)   
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

